Login / Signup

Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19.

Kerri BertrandYadira SepulvedaBenjamin J SpiegelBrookie M BestRaymond SuhandynataSteven RossiChristina D ChambersJeremiah D Momper
Published in: Pediatric research (2024)
Findings from this study provide further reassuring evidence that infant exposure through human milk received from lactating individuals who require treatment with remdesivir is negligible.
Keyphrases
  • human milk
  • low birth weight
  • dairy cows
  • coronavirus disease
  • preterm infants
  • heat stress
  • sars cov
  • preterm birth
  • combination therapy
  • replacement therapy